Amino.Desk

About Amino Desk

Updated Nov 14, 2026

Amino Desk is an independent publication covering peptides and GLP-1 medications for people deciding whether, and how, to use them.

Why it exists

Most of what is written about peptides is written by someone selling them. Protocols end in a checkout link, animal studies are presented as proof, and legal status is skipped. Meanwhile the rules have changed several times in two years. We started Amino Desk to answer three plain questions about each compound: is there a lawful way to get it, what has actually been shown in people, and what does it cost.

What you will find here

How we work

The full standards are in the editorial policy.

Independence

Amino Desk is independently owned. It is not owned by, or affiliated with, any pharmacy, telehealth company, drug manufacturer or peptide vendor. Our affiliate disclosure sets out how any commercial relationships are handled and labelled.

What we will not do

Who we are not

Amino Desk is not a pharmacy, clinic or medical provider, and nothing here is medical advice. Decisions about medication belong with you and a licensed clinician who knows your history.

Corrections

If something here is wrong or out of date, tell us. We fix errors promptly and update the page date when we do.

Contact

General questions: hello@aminodesk.com
Corrections: corrections@aminodesk.com

Free cheat sheet

Thirty peptides and GLP-1s on one page: who can legally get what, and how strong the evidence is. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy